Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...

If approved, a subcutaneous formulation of anifrolumab would allow patients the ability to self-administer the medication outside of a hospital or clinic setting. The Food and Drug Administration (FDA ...

Chronic muscle tension is a common underlying factor in many pain disorders, causing reduced arterial blood flow, tissue hypoxia, and the release of inflammatory mediators. These physiological changes ...

Get your car ready for winter with these five essential fluid checks. Prevent breakdowns and stay safe before temperatures drop. A quick winter check now can prevent big problems later Low or old ...

During the height of Super Smash Bros. Ultimate, the FGC flocked to Masahiro Sakurai’s X account to look for clues and hints on the next DLC fighter. They’d also get to see some insight into his life, ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

Compared with placebo, significantly greater proportions of patients treated with Tremfya achieved clinical remission and endoscopic improvement. HealthDay News — The US Food and Drug Administration ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately ...

Merck (NYSE:MRK) said that the FDA has cleared Keytruda Qlex, a new subcutaneous version of its blockbuster cancer drug, offering a faster alternative to IV infusion, a company spokesperson confirmed ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.

ROCHESTER, N.Y. — Seneca Park Zoo has made a treatment plan after Katya, a 20-year-old Amur tiger, was diagnosed with early-stage chronic kidney disease. Katya is the oldest tiger in any zoo part of ...